Cargando…

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort

Cross sectional studies of patients at risk of developing Alzheimer disease (AD) have identified several brain regions known to be prone to degeneration suitable as biomarkers, including hippocampal, ventricular, and whole brain volume. The aim of this study was to longitudinally evaluate an index b...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Carlos, Muehlboeck, J-Sebastian, Mecocci, Patrizia, Vellas, Bruno, Tsolaki, Magda, Kloszewska, Iwona, Soininen, Hilkka, Lovestone, Simon, Wahlund, Lars-Olof, Simmons, Andrew, Westman, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094911/
https://www.ncbi.nlm.nih.gov/pubmed/25071554
http://dx.doi.org/10.3389/fnagi.2014.00145
_version_ 1782325920308133888
author Aguilar, Carlos
Muehlboeck, J-Sebastian
Mecocci, Patrizia
Vellas, Bruno
Tsolaki, Magda
Kloszewska, Iwona
Soininen, Hilkka
Lovestone, Simon
Wahlund, Lars-Olof
Simmons, Andrew
Westman, Eric
author_facet Aguilar, Carlos
Muehlboeck, J-Sebastian
Mecocci, Patrizia
Vellas, Bruno
Tsolaki, Magda
Kloszewska, Iwona
Soininen, Hilkka
Lovestone, Simon
Wahlund, Lars-Olof
Simmons, Andrew
Westman, Eric
author_sort Aguilar, Carlos
collection PubMed
description Cross sectional studies of patients at risk of developing Alzheimer disease (AD) have identified several brain regions known to be prone to degeneration suitable as biomarkers, including hippocampal, ventricular, and whole brain volume. The aim of this study was to longitudinally evaluate an index based on morphometric measures derived from MRI data that could be used for classification of AD and healthy control subjects, as well as prediction of conversion from mild cognitive impairment (MCI) to AD. Patients originated from the AddNeuroMed project at baseline (119 AD, 119 MCI, 110 controls (CTL)) and 1-year follow-up (62 AD, 73 MCI, 79 CTL). Data consisted of 3D T1-weighted MR images, demographics, MMSE, ADAS-Cog, CERAD and CDR scores, and APOE e4 status. We computed an index using a multivariate classification model (AD vs. CTL), using orthogonal partial least squares to latent structures (OPLS). Sensitivity, specificity and AUC were determined. Performance of the classifier (AD vs. CTL) was high at baseline (10-fold cross-validation, 84% sensitivity, 91% specificity, 0.93 AUC) and at 1-year follow-up (92% sensitivity, 74% specificity, 0.93 AUC). Predictions of conversion from MCI to AD were good at baseline (77% of MCI converters) and at follow-up (91% of MCI converters). MCI carriers of the APOE e4 allele manifested more atrophy and presented a faster cognitive decline when compared to non-carriers. The derived index demonstrated a steady increase in atrophy over time, yielding higher accuracy in prediction at the time of clinical conversion. Neuropsychological tests appeared less sensitive to changes over time. However, taking the average of the two time points yielded better correlation between the index and cognitive scores as opposed to using cross-sectional data only. Thus, multivariate classification seemed to detect patterns of AD changes before conversion from MCI to AD and including longitudinal information is of great importance.
format Online
Article
Text
id pubmed-4094911
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40949112014-07-28 Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort Aguilar, Carlos Muehlboeck, J-Sebastian Mecocci, Patrizia Vellas, Bruno Tsolaki, Magda Kloszewska, Iwona Soininen, Hilkka Lovestone, Simon Wahlund, Lars-Olof Simmons, Andrew Westman, Eric Front Aging Neurosci Neuroscience Cross sectional studies of patients at risk of developing Alzheimer disease (AD) have identified several brain regions known to be prone to degeneration suitable as biomarkers, including hippocampal, ventricular, and whole brain volume. The aim of this study was to longitudinally evaluate an index based on morphometric measures derived from MRI data that could be used for classification of AD and healthy control subjects, as well as prediction of conversion from mild cognitive impairment (MCI) to AD. Patients originated from the AddNeuroMed project at baseline (119 AD, 119 MCI, 110 controls (CTL)) and 1-year follow-up (62 AD, 73 MCI, 79 CTL). Data consisted of 3D T1-weighted MR images, demographics, MMSE, ADAS-Cog, CERAD and CDR scores, and APOE e4 status. We computed an index using a multivariate classification model (AD vs. CTL), using orthogonal partial least squares to latent structures (OPLS). Sensitivity, specificity and AUC were determined. Performance of the classifier (AD vs. CTL) was high at baseline (10-fold cross-validation, 84% sensitivity, 91% specificity, 0.93 AUC) and at 1-year follow-up (92% sensitivity, 74% specificity, 0.93 AUC). Predictions of conversion from MCI to AD were good at baseline (77% of MCI converters) and at follow-up (91% of MCI converters). MCI carriers of the APOE e4 allele manifested more atrophy and presented a faster cognitive decline when compared to non-carriers. The derived index demonstrated a steady increase in atrophy over time, yielding higher accuracy in prediction at the time of clinical conversion. Neuropsychological tests appeared less sensitive to changes over time. However, taking the average of the two time points yielded better correlation between the index and cognitive scores as opposed to using cross-sectional data only. Thus, multivariate classification seemed to detect patterns of AD changes before conversion from MCI to AD and including longitudinal information is of great importance. Frontiers Media S.A. 2014-07-14 /pmc/articles/PMC4094911/ /pubmed/25071554 http://dx.doi.org/10.3389/fnagi.2014.00145 Text en Copyright © 2014 Aguilar, Muehlboeck, Mecocci, Vellas, Tsolaki, Kloszewska, Soininen, Lovestone, Wahlund, Simmons and Westman. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Aguilar, Carlos
Muehlboeck, J-Sebastian
Mecocci, Patrizia
Vellas, Bruno
Tsolaki, Magda
Kloszewska, Iwona
Soininen, Hilkka
Lovestone, Simon
Wahlund, Lars-Olof
Simmons, Andrew
Westman, Eric
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title_full Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title_fullStr Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title_full_unstemmed Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title_short Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
title_sort application of a mri based index to longitudinal atrophy change in alzheimer disease, mild cognitive impairment and healthy older individuals in the addneuromed cohort
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094911/
https://www.ncbi.nlm.nih.gov/pubmed/25071554
http://dx.doi.org/10.3389/fnagi.2014.00145
work_keys_str_mv AT aguilarcarlos applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT muehlboeckjsebastian applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT mecoccipatrizia applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT vellasbruno applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT tsolakimagda applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT kloszewskaiwona applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT soininenhilkka applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT lovestonesimon applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT wahlundlarsolof applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT simmonsandrew applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT westmaneric applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort
AT applicationofamribasedindextolongitudinalatrophychangeinalzheimerdiseasemildcognitiveimpairmentandhealthyolderindividualsintheaddneuromedcohort